Billionaire businessman Mark Cuban, a vocal critic of Elon Musk‘s management of the social-media platform X, responded to Musk’s inquiry about the anti-parasitic treatment, ivermectin.
What happened: A user on the X platform with the handle @MdBreathe questioned Cuban in June about why his Cost Plus Drugs company doesn’t offer ivermectin, highlighting the stark pricing difference between Africa and the U.S. “Why does your company not offer ivermectin? Ivermectin costs $0.02 per pill in Africa, 100x mark-up in America,” the user pointed out.
Cuban’s Cost Plus Drugs company, a public benefit corporation in Dallas, Texas, provides generic drugs at lower prices by eliminating middlemen and using a cost-plus pricing strategy.
Musk interjected, responding to the June post, “Good question.”
In his reply, Cuban explained that his company couldn’t secure a better price than other available sources but offered Hydroxychloroquine instead, a product his company sells.
Cuban also ...